[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367101-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367101-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-x-linked-tumor-suppressor-tspx-regulates-genes-involved-in-the-egfr-signaling-pathway-and-cell-viability-to-suppress-lung-adenocarcinoma","The X-Linked Tumor Suppressor TSPX Regulates Genes Involved in the EGFR Signaling Pathway and Cell Viability to Suppress Lung Adenocarcinoma","","TSPX is an X-linked tumor suppressor originally found in non-small cell lung cancer (NSCLC) models, yet its expression patterns and downstream mechanisms remained unclear. This study assessed TSPX function in NSCLC by combining RNA-seq transcriptome and pathway enrichment analyses in TSPX-overexpressing A549 and SK-MES-1 cells with clinical correlation using TCGA cohorts. Results show TSPX downregulation in NSCLC, inverse association with cancer stage, and improved survival in lung adenocarcinoma. TSPX altered cancer-relevant signaling genes, notably suppressing EGFR-pathway targets such as AREG, EREG, FOSL1, and MYC, implicating TSPX as a biomarker and therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-x-linked-tumor-suppressor-tspx-regulates-genes-involved-in-the-egfr-signaling-pathway-and-cell-viability-to-suppress-lung-adenocarcinoma/367101/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-x-linked-tumor-suppressor-tspx-regulates-genes-involved-in-the-egfr-signaling-pathway-and-cell-viability-to-suppress-lung-adenocarcinoma/367101.png","ImageObject",300,407,{"name":42,"@type":43},"Olivia Brown","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does this study address about TSPX in NSCLC?","Question",{"text":63,"@type":64},"It investigates TSPX expression patterns and downstream mechanisms in NSCLC, which were previously unclear, and links them to potential targets and clinical outcomes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were TSPX functions studied experimentally?",{"text":68,"@type":64},"RNA-seq transcriptome profiling and pathway enrichment analyses were performed on TSPX-overexpressing NSCLC cell lines, including A549 and SK-MES-1.",{"name":70,"@type":61,"acceptedAnswer":71},"What clinical relationship was observed between TSPX levels and lung adenocarcinoma outcomes?",{"text":72,"@type":64},"TSPX was downregulated in NSCLC tumors, showed an inverse correlation with cancer stage, and higher TSPX levels were associated with better survival in lung adenocarcinoma.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367101,1790196330,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Article  \nThe X-Linked Tumor Suppressor TSPX Regulates Genes Involved in the EGFR Signaling Pathway and Cell Viability to Suppress Lung Adenocarcinoma  \nTatsuo Kido , Hui Kong † and Yun-Fai Chris Lau *  \nAcademic Editors: Paolo Cinelli and Sudheer Kumar Gara  \nReceived: 7 December 2024  \nRevised: 2 January 2025  \nAccepted: 9 January 2025  \nPublished: 11 January 2025  \nCitation: Kido, T.; Kong, H.; Lau, Y.-F.C. The X-Linked Tumor Suppressor TSPX Regulates Genes Involved in the EGFR Signaling Pathway and Cell Viability to Suppress Lung Adenocarcinoma. Genes 2025, 16, 75. [https://](https://)[ ](https://)[doi.org/10.3390/genes16010075](doi.org/10.3390/genes16010075)  \n[Copyright:](Copyright:) © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \nDivision of Cell and Developmental Genetics, Department of Medicine, Veterans Affairs Medical Center, and the Institute for Human Genetics, University of California, San Francisco, CA 94121, USA;  \n[tatsuo.kido@ucsf.edu](tatsuo.kido@ucsf.edu) (T.K.); [konghui@njmu.edu.cn](konghui@njmu.edu.cn) (H.K.)  \n* Correspondence: [chris.lau@ucsf.edu](chris.lau@ucsf.edu); Tel.: +1-415-397-5526  \n† Current address: Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.  \nAbstract: Background: TSPX is an X-linked tumor suppressor that was initially identified in non-small cell lung cancer (NSCLC) cell lines. However, its expression patterns and downstream mechanisms in NSCLC remain unclear. This study aims to investigate the functions of TSPX in NSCLC by identifying its potential downstream targets and their correlation with clinical outcomes. Methods: RNA-seq transcriptome and pathway enrichment analyses were conducted on the TSPX-overexpressing NSCLC cell lines, A549 and SK-MES-1, originating from lung adenocarcinoma and squamous cell carcinoma subtypes, respectively. In addition, comparative analyses were performed using the data from clinical NSCLC specimens (515 lung adenocarcinomas and 502 lung squamous cell carcinomas) in the Cancer Genome Atlas (TCGA) database. Results: TCGA data analysis revealed significant downregulation of TSPX in NSCLC tumors compared to adjacent non-cancerous tissues (Wilcoxon matched pairs signed rank test p \u003C 0.0001) . Notably, the TSPX expression levels were inversely correlated with the cancer stage, and higher TSPX levels were associated with better clinical outcomes and improved survival in lung adenocarcinoma, a subtype of NSCLC (median survival extended by 510 days; log-rank test, p = 0.0025) . RNA-seq analysis of the TSPX-overexpressing NSCLC cell lines revealed that TSPX regulates various genes involved in the cancer-related signaling pathways and cell viability, consistent with the suppression of cell proliferation in cell culture assays. Notably, various potential downstream targets of TSPX that correlated with patient survival (log-rank test, p = 0.016 to 4.3 × 10−10) were identified, including EGFR pathway-related genes AREG, EREG, FOSL1, and MYC, which were downregulated. Conclusions: Our results suggest that TSPX plays a critical role in suppressing NSCLC progression by downregulating prooncogenic genes, particularly those in the EGFR signaling pathway, and upregulating the tumor suppressors, especially in lung adenocarcinoma. These findings suggest that TSPX is a potential biomarker and therapeutic target for NSCLC management.  \nKeywords: TSPX; DENTT; lung adenocarcinoma; non-small cell lung cancer; RNA-seq; X-linked tumor suppressor; EGFR signaling pathway  \n1. Introduction  \nLung cancer is the leading cause of cancer death worldwide, approximately 1.76 million death each year (18.4% of the total cancer ","cbCailjQLesJv3uO","https://ap.wps.com/l/cbCailjQLesJv3uO","pdf",6172112,"English","# Introduction\n## TSPX as an X-linked tumor suppressor\n## EGFR signaling and NSCLC prognosis\n# Methods and analyses\n## RNA-seq and pathway enrichment\n## TCGA clinical correlation","[{\"question\":\"What problem does this study address about TSPX in NSCLC?\",\"answer\":\"It investigates TSPX expression patterns and downstream mechanisms in NSCLC, which were previously unclear, and links them to potential targets and clinical outcomes.\"},{\"question\":\"How were TSPX functions studied experimentally?\",\"answer\":\"RNA-seq transcriptome profiling and pathway enrichment analyses were performed on TSPX-overexpressing NSCLC cell lines, including A549 and SK-MES-1.\"},{\"question\":\"What clinical relationship was observed between TSPX levels and lung adenocarcinoma outcomes?\",\"answer\":\"TSPX was downregulated in NSCLC tumors, showed an inverse correlation with cancer stage, and higher TSPX levels were associated with better survival in lung adenocarcinoma.\"}]","The X-Linked Tumor Suppressor TSPX Regulates Genes Involved in the EGFR Signaling Pathway and Cell Viability to Suppress Lung Adenocarcinoma | PDF",1790169280,48,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fdff0dc070ed9c84d0c7917085fa4eca.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9920983fa860df83620724760c6ae3d0.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7f9b90189fc280e04884eb5a9bc4468b.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c6d33585b25facf5accfede4c81ee529.webp",980,1385]